Phase I Study of Rituximab, Lenalidomide, and Ibrutinib in Previously Untreated Follicular Lymphoma (Alliance 051103)

被引：7

作者：

Ujjani, Chaitra S. ^{[1
]}

Jung, Sin-Ho ^{[2
]}

Pitcher, Brandelyn ^{[3
]}

Martin, Peter ^{[4
]}

Park, Steven I. ^{[5
]}

Blum, Kristie A. ^{[6
]}

Smith, Sonali M. ^{[7
]}

Czuczman, Myron S. ^{[8
]}

Davids, Matthew S. ^{[9
]}

Leonard, John P. ^{[10
]}

Cheson, Bruce D. ^{[1
]}

机构：

[1] Georgetown Univ Hosp, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

[2] Duke Univ, Alliance Stat & Data Ctr, Durham, NC USA

[3] Duke Univ, Med Ctr, Durham, NC USA

[4] Weill Cornell Med Coll, Div Hematol Oncol, New York, NY USA

[5] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

[6] Ohio State Univ, Div Hematol, Columbus, OH 43210 USA

[7] Univ Chicago, Chicago, IL 60637 USA

[8] Celgene Corp, Summit, NJ USA

[9] Dana Farber Canc Inst, Boston, MA 02115 USA

[10] Weill Cornell Med Coll, Dept Med, New York, NY USA

来源：

关键词：

D O I：

10.1182/blood.V126.23.471.471

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3